Neogen Corp (NEOG) USD0.16
Sell:$83.55
Buy:$83.57
Change:
No change
No change
NASDAQ:0.87%
- Add to watchlist
- This stock can be held in a
Sell:$83.55
Buy:$83.57
Change:
No change
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Sell:$83.55
Buy:$83.57
Change:
No change
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
| Date | Name | Position (if held) | Deal type | Number of shares dealt |
Price | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|---|
| 13 Jan 2021 | Papesh, G Bruce | Director | Sell (option related) | 30,000.00 | $83.40 | $2,502,063.00 | 36,261.00 |
| 07 Jan 2021 | Quinlan, Steven J | CFO | Sell (option related) | 9,333.00 | $84.49 | $788,525.57 | 13,470.00 |
| 07 Jan 2021 | Adent, John Edward | President/CEO | Sell (option related) | 20,000.00 | $84.18 | $1,683,694.00 | 16,080.00 |
| 06 Jan 2021 | Lilly, Jason Warren | Vice President | Sell (option related) | 11,021.00 | $82.91 | $913,715.84 | 13,611.00 |
| 05 Jan 2021 | Boehm, William T | Independent Director | Sell (option related) | 3,000.00 | $80.72 | $242,170.80 | 10,479.00 |
| 16 Nov 2020 | Lilly, Jason Warren | Vice President | Sell (option related) | 14,378.00 | $73.23 | $1,052,913.63 | 12,032.00 |
| 03 Nov 2020 | Quinlan, Steven J | CFO | Sell (option related) | 6,666.00 | $70.54 | $470,239.64 | 13,470.00 |
| 02 Nov 2020 | Quinlan, Steven J | CFO | Sell (option related) | 800.00 | $70.55 | $56,437.04 | 13,470.00 |
| 21 Oct 2020 | Lilly, Jason Warren | Vice President | Sell (option related) | 6,666.00 | $70.62 | $470,770.25 | 10,409.00 |
| 14 Oct 2020 | Herbert, James L | Director | Sell (option related) | 25,333.00 | $70.91 | $1,796,332.63 | 41,951.00 |
| 30 Sep 2020 | Herbert, James L | Director | Sell (option related) | 25,333.00 | $78.61 | $1,991,361.26 | 41,951.00 |
| 13 Jan 2021 | Papesh, G Bruce | Director | Sell (option related) | 30,000.00 | $83.40 | $2,502,063.00 | 36,261.00 |
| 07 Jan 2021 | Quinlan, Steven J | CFO | Sell (option related) | 9,333.00 | $84.49 | $788,525.57 | 13,470.00 |
| 07 Jan 2021 | Adent, John Edward | President/CEO | Sell (option related) | 20,000.00 | $84.18 | $1,683,694.00 | 16,080.00 |
| 06 Jan 2021 | Lilly, Jason Warren | Vice President | Sell (option related) | 11,021.00 | $82.91 | $913,715.84 | 13,611.00 |
| 05 Jan 2021 | Boehm, William T | Independent Director | Sell (option related) | 3,000.00 | $80.72 | $242,170.80 | 10,479.00 |
| 16 Nov 2020 | Lilly, Jason Warren | Vice President | Sell (option related) | 14,378.00 | $73.23 | $1,052,913.63 | 12,032.00 |
| 03 Nov 2020 | Quinlan, Steven J | CFO | Sell (option related) | 6,666.00 | $70.54 | $470,239.64 | 13,470.00 |
| 02 Nov 2020 | Quinlan, Steven J | CFO | Sell (option related) | 800.00 | $70.55 | $56,437.04 | 13,470.00 |
| 21 Oct 2020 | Lilly, Jason Warren | Vice President | Sell (option related) | 6,666.00 | $70.62 | $470,770.25 | 10,409.00 |
| 14 Oct 2020 | Herbert, James L | Director | Sell (option related) | 25,333.00 | $70.91 | $1,796,332.63 | 41,951.00 |
| 30 Sep 2020 | Herbert, James L | Director | Sell (option related) | 25,333.00 | $78.61 | $1,991,361.26 | 41,951.00 |
| 05 Aug 2020 | Lilly, Jason Warren | Vice President | Sell (option related) | 5,681.00 | $80.08 | $454,932.21 | 10,409.00 |
| 13 Jan 2021 | Papesh, G Bruce | Director | Sell (option related) | 30,000.00 | $83.40 | $2,502,063.00 | 36,261.00 |
| 07 Jan 2021 | Quinlan, Steven J | CFO | Sell (option related) | 9,333.00 | $84.49 | $788,525.57 | 13,470.00 |
| 07 Jan 2021 | Adent, John Edward | President/CEO | Sell (option related) | 20,000.00 | $84.18 | $1,683,694.00 | 16,080.00 |
| 06 Jan 2021 | Lilly, Jason Warren | Vice President | Sell (option related) | 11,021.00 | $82.91 | $913,715.84 | 13,611.00 |
| 05 Jan 2021 | Boehm, William T | Independent Director | Sell (option related) | 3,000.00 | $80.72 | $242,170.80 | 10,479.00 |
| 16 Nov 2020 | Lilly, Jason Warren | Vice President | Sell (option related) | 14,378.00 | $73.23 | $1,052,913.63 | 12,032.00 |
| 03 Nov 2020 | Quinlan, Steven J | CFO | Sell (option related) | 6,666.00 | $70.54 | $470,239.64 | 13,470.00 |
| 02 Nov 2020 | Quinlan, Steven J | CFO | Sell (option related) | 800.00 | $70.55 | $56,437.04 | 13,470.00 |
| 21 Oct 2020 | Lilly, Jason Warren | Vice President | Sell (option related) | 6,666.00 | $70.62 | $470,770.25 | 10,409.00 |
| 14 Oct 2020 | Herbert, James L | Director | Sell (option related) | 25,333.00 | $70.91 | $1,796,332.63 | 41,951.00 |
| 30 Sep 2020 | Herbert, James L | Director | Sell (option related) | 25,333.00 | $78.61 | $1,991,361.26 | 41,951.00 |
| 05 Aug 2020 | Lilly, Jason Warren | Vice President | Sell (option related) | 5,681.00 | $80.08 | $454,932.21 | 10,409.00 |
| 05 May 2020 | Lilly, Jason Warren | Vice President | Regular sell transaction (market) | 885.00 | $64.00 | $56,640.00 | 10,409.00 |
| 21 Apr 2020 | Herbert, James L | Director | Regular sell transaction (market) | 19,368.00 | $66.13 | $1,280,834.89 | 604.00 |
| 03 Apr 2020 | Herbert, James L | Chairman of the Board | Regular sell transaction (market) | 20,000.00 | $63.16 | $1,263,200.00 | 19,972.00 |
| 26 Mar 2020 | Tobin, James P | Independent Director | Regular purchase transaction | 734.00 | $60.62 | $44,495.08 | 5,500.00 |
| 25 Mar 2020 | Adent, John Edward | President/CEO | Regular purchase transaction | 1,750.00 | $58.24 | $101,920.00 | 16,080.00 |
| 18 Feb 2020 | Herbert, James L | Chairman of the Board | Regular sell transaction (market) | 14,614.00 | $72.04 | $1,052,862.71 | 89,456.00 |
| 14 Feb 2020 | Lilly, Jason Warren | Vice President | Sell (option related) | 7,107.00 | $72.75 | $517,039.94 | 11,294.00 |
| 12 Feb 2020 | Quinlan, Steven J | CFO | Sell (option related) | 899.00 | $72.25 | $64,952.75 | 13,470.00 |
| 11 Feb 2020 | Quinlan, Steven J | CFO | Sell (option related) | 12,103.00 | $72.00 | $871,417.21 | 13,470.00 |
| 10 Feb 2020 | Lilly, Jason Warren | Vice President | Sell (option related) | 7,120.00 | $70.01 | $498,471.20 | 10,401.00 |
| 10 Feb 2020 | Herbert, James L | Chairman of the Board | Regular sell transaction (market) | 30,000.00 | $69.72 | $2,091,543.00 | 126,570.00 |
| 06 Feb 2020 | Lilly, Jason Warren | Vice President | Sell (option related) | 1,472.00 | $70.01 | $103,054.72 | 10,401.00 |
| 05 Feb 2020 | Lilly, Jason Warren | Vice President | Sell (option related) | 3,892.00 | $70.02 | $272,517.84 | 10,401.00 |
| 03 Feb 2020 | Herbert, James L | Chairman of the Board | Regular sell transaction (market) | 30,000.00 | $68.33 | $2,049,787.00 | 156,970.00 |
| 24 Jan 2020 | Reed, Thomas H | Independent Director | Sell (option related) | 1,000.00 | $69.76 | $69,760.00 | 8,010.00 |
| Date | Name | Position (if held) | Deal type | Number of shares dealt |
Price | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|---|
| 13 Jan 2021 | Papesh, G Bruce | Director | Sell (option related) | 30,000 | $83.40 | $2,502,063.00 | 36,261.00 |
| 30 Sep 2020 | Herbert, James L | Director | Sell (option related) | 25,333 | $78.61 | $1,991,361.26 | 41,951.00 |
| 14 Oct 2020 | Herbert, James L | Director | Sell (option related) | 25,333 | $70.91 | $1,796,332.63 | 41,951.00 |
| 07 Jan 2021 | Adent, John Edward | President/CEO | Sell (option related) | 20,000 | $84.18 | $1,683,694.00 | 16,080.00 |
| 16 Nov 2020 | Lilly, Jason Warren | Vice President | Sell (option related) | 14,378 | $73.23 | $1,052,913.63 | 12,032.00 |
| 13 Jan 2021 | Papesh, G Bruce | Director | Sell (option related) | 30,000 | $83.40 | $2,502,063.00 | 36,261.00 |
| 30 Sep 2020 | Herbert, James L | Director | Sell (option related) | 25,333 | $78.61 | $1,991,361.26 | 41,951.00 |
| 14 Oct 2020 | Herbert, James L | Director | Sell (option related) | 25,333 | $70.91 | $1,796,332.63 | 41,951.00 |
| 07 Jan 2021 | Adent, John Edward | President/CEO | Sell (option related) | 20,000 | $84.18 | $1,683,694.00 | 16,080.00 |
| 16 Nov 2020 | Lilly, Jason Warren | Vice President | Sell (option related) | 14,378 | $73.23 | $1,052,913.63 | 12,032.00 |
| 13 Jan 2021 | Papesh, G Bruce | Director | Sell (option related) | 30,000 | $83.40 | $2,502,063.00 | 36,261.00 |
| 10 Feb 2020 | Herbert, James L | Chairman of the Board | Regular sell transaction (market) | 30,000 | $69.72 | $2,091,543.00 | 126,570.00 |
| 03 Feb 2020 | Herbert, James L | Chairman of the Board | Regular sell transaction (market) | 30,000 | $68.33 | $2,049,787.00 | 156,970.00 |
| 30 Sep 2020 | Herbert, James L | Director | Sell (option related) | 25,333 | $78.61 | $1,991,361.26 | 41,951.00 |
| 14 Oct 2020 | Herbert, James L | Director | Sell (option related) | 25,333 | $70.91 | $1,796,332.63 | 41,951.00 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.